[1]
Nguyen HB, Rivers EP, Abrahamian FM, Moran GJ, Abraham E, Trzeciak S, Huang DT, Osborn T, Stevens D, Talan DA, Emergency Department Sepsis Education Program and Strategies to Improve Survival (ED-SEPSIS) Working Group. Severe sepsis and septic shock: review of the literature and emergency department management guidelines. Annals of emergency medicine. 2006 Jul:48(1):28-54
[PubMed PMID: 16781920]
[2]
Mayr FB, Yende S, Linde-Zwirble WT, Peck-Palmer OM, Barnato AE, Weissfeld LA, Angus DC. Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis. JAMA. 2010 Jun 23:303(24):2495-503. doi: 10.1001/jama.2010.851. Epub
[PubMed PMID: 20571016]
[3]
Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K, EPIC II Group of Investigators. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009 Dec 2:302(21):2323-9. doi: 10.1001/jama.2009.1754. Epub
[PubMed PMID: 19952319]
[4]
Rangel-Frausto MS. The epidemiology of bacterial sepsis. Infectious disease clinics of North America. 1999 Jun:13(2):299-312, vii
[PubMed PMID: 10340168]
[5]
Cohen J, Cristofaro P, Carlet J, Opal S. New method of classifying infections in critically ill patients. Critical care medicine. 2004 Jul:32(7):1510-26
[PubMed PMID: 15241096]
[6]
Annane D, Aegerter P, Jars-Guincestre MC, Guidet B, CUB-Réa Network. Current epidemiology of septic shock: the CUB-Réa Network. American journal of respiratory and critical care medicine. 2003 Jul 15:168(2):165-72
[PubMed PMID: 12851245]
[7]
Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. The New England journal of medicine. 2003 Apr 17:348(16):1546-54
[PubMed PMID: 12700374]
[8]
Elixhauser A, Friedman B, Stranges E. Septicemia in U.S. Hospitals, 2009. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. 2006 Feb:():
[PubMed PMID: 22049570]
[9]
Torio CM, Andrews RM. National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2011. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. 2006 Feb:():
[PubMed PMID: 24199255]
[10]
Elfeky S, Golabi P, Otgonsuren M, Djurkovic S, Schmidt ME, Younossi ZM. The epidemiologic characteristics, temporal trends, predictors of death, and discharge disposition in patients with a diagnosis of sepsis: A cross-sectional retrospective cohort study. Journal of critical care. 2017 Jun:39():48-55. doi: 10.1016/j.jcrc.2017.01.006. Epub 2017 Jan 20
[PubMed PMID: 28199891]
Level 2 (mid-level) evidence
[11]
Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Critical care medicine. 2001 Jul:29(7):1303-10
[PubMed PMID: 11445675]
[12]
Liu V, Escobar GJ, Greene JD, Soule J, Whippy A, Angus DC, Iwashyna TJ. Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA. 2014 Jul 2:312(1):90-2
[PubMed PMID: 24838355]
[13]
Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet (London, England). 2005 Jan 1-7:365(9453):63-78
[PubMed PMID: 15639681]
[14]
Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992 Jun:101(6):1644-55
[PubMed PMID: 1303622]
Level 3 (low-level) evidence
[15]
Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. The New England journal of medicine. 2003 Jan 9:348(2):138-50
[PubMed PMID: 12519925]
[16]
Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Critical care medicine. 2003 Apr:31(4):1250-6
[PubMed PMID: 12682500]
[17]
Jones AE, Puskarich MA. The Surviving Sepsis Campaign guidelines 2012: update for emergency physicians. Annals of emergency medicine. 2014 Jan:63(1):35-47. doi: 10.1016/j.annemergmed.2013.08.004. Epub 2013 Sep 23
[PubMed PMID: 24067755]
[18]
Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Critical care medicine. 2017 Mar:45(3):486-552. doi: 10.1097/CCM.0000000000002255. Epub
[PubMed PMID: 28098591]
[19]
Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. The New England journal of medicine. 2001 Nov 8:345(19):1368-77
[PubMed PMID: 11794169]
[20]
Ventura AM, Shieh HH, Bousso A, Góes PF, de Cássia F O Fernandes I, de Souza DC, Paulo RL, Chagas F, Gilio AE. Double-Blind Prospective Randomized Controlled Trial of Dopamine Versus Epinephrine as First-Line Vasoactive Drugs in Pediatric Septic Shock. Critical care medicine. 2015 Nov:43(11):2292-302. doi: 10.1097/CCM.0000000000001260. Epub
[PubMed PMID: 26323041]
Level 1 (high-level) evidence
[22]
Annane D, Renault A, Bellissant E. Glucocorticoids with or without Fludrocortisone in Septic Shock. The New England journal of medicine. 2018 Aug 30:379(9):895-6. doi: 10.1056/NEJMc1804993. Epub
[PubMed PMID: 30179381]
[23]
Cardenas-Garcia J, Schaub KF, Belchikov YG, Narasimhan M, Koenig SJ, Mayo PH. Safety of peripheral intravenous administration of vasoactive medication. Journal of hospital medicine. 2015 Sep:10(9):581-5. doi: 10.1002/jhm.2394. Epub 2015 May 26
[PubMed PMID: 26014852]
[24]
Angus DC, Barnato AE, Bell D, Bellomo R, Chong CR, Coats TJ, Davies A, Delaney A, Harrison DA, Holdgate A, Howe B, Huang DT, Iwashyna T, Kellum JA, Peake SL, Pike F, Reade MC, Rowan KM, Singer M, Webb SA, Weissfeld LA, Yealy DM, Young JD. A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators. Intensive care medicine. 2015 Sep:41(9):1549-60. doi: 10.1007/s00134-015-3822-1. Epub 2015 May 8
[PubMed PMID: 25952825]
Level 1 (high-level) evidence
[25]
Osborn TM. Severe Sepsis and Septic Shock Trials (ProCESS, ARISE, ProMISe): What is Optimal Resuscitation? Critical care clinics. 2017 Apr:33(2):323-344. doi: 10.1016/j.ccc.2016.12.004. Epub
[PubMed PMID: 28284298]